Circadian rhythm of blood pressure in diabetes mellitus: Evidence, mechanisms and implications

Current Diabetes Reviews

Volumn 8, Issue 5, 2012, Pages 355-361

  Matteucci, Elena ^a   Giampietro, Ottavio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Acrophase; Ambulatory Blood Pressure Monitoring; Circadian Rhythm; Diabetes Mellitus; Essential Hypertension; Midline Estimating Statistic of Rhythm; Outcome Assessment; Type

Indexed keywords

BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DISEASE COURSE; HEART FUNCTION; HEART RATE; HUMAN; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; RISK FACTORS;

EID: 84866640674     PISSN: 15733998     EISSN: 18756417     Source Type: Journal    
DOI: 10.2174/157339912802083496     Document Type: Review

References (84)

1. Litinski M, Scheer FA, Shea SA. Influence of the Circadian Systemon Disease Severity. Sleep Med Clin 2009; 4: 143-63.
2. Hjalmarson A, Gilpin EA, Nicod P, et al. Differing circadian patternsof symptom onset in subgroups of patients with acute myocardialinfarction. Circulation 1989; 80:267-75.
3. Zarich S, Waxman S, Freeman RT, Mittleman M, Hegarty P, NestoRW. Effect of autonomic nervous system dysfunction on the circadianpattern of myocardial ischemia in diabetes mellitus. J AmCollCardiol 1994; 24: 956-62.
4. Cannon CP, McCabe CH, Stone PH, et al. Circadian variation inthe onset of unstable angina and non-Q-wave acute myocardial infarction(the TIMI III Registry and TIMI IIIB). Am J Cardiol 1997;79: 253-8.
5. Rana JS, Mukamal KJ, Morgan JP, Muller JE, Mittleman MA. Circadian variation in the onset of myocardial infarction: effect ofduration of diabetes. Diabetes 2003; 52: 1464-8.
6. Li J, Hua Q, Pi L, Tan J, Li B. Circadian variation on the onset ofacute ST segment elevation myocardial infarction in diabetic subjects. J Cardiovasc Dis Res 2010; 1: 23-6.
7. Takeda N, Maemura K. Circadian clock and cardiovascular disease. J Cardiol 2011; 57: 249-56.
8. Durgan DJ, Young ME. The cardiomyocyte circadian clock:emerging roles in health and disease. Circ Res 2010; 106:647-58.
9. Froy O. Metabolism and circadian rhythms-implications for obesity. Endocr Rev 2010; 31: 1-24.
10. O'Neill JS, Reddy AB. Circadian clocks in human red blood cells. Nature 2011; 469: 498-503.
11. Mancia G, De Backer G, Dominiczak A, et al.; Management ofArterial Hypertension of the European Society of Hypertension;European Society of Cardiology.2007 Guidelines for the Managementof Arterial Hypertension: The Task Force for the Managementof Arterial Hypertension of the European Society of Hypertension(ESH) and of the European Society of Cardiology (ESC). JHypertens 2007; 25: 1105-87.
12. American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care 2012; 35: S11-63.
13. Eguchi K. Ambulatory blood pressure monitoring in diabetes andobesity-A review. Int J Hypertens 2011; 2011: 954757.
14. Parati G, Bilo G. Should 24-h ambulatory blood pressure monitoringbe done in every patient with diabetes? Diabetes Care 2009; 32:S298-304.
15. Nakano S, Uchida K, Kigoshi T, et al. Circadian rhythm of bloodpressure in normotensive NIDDM subjects. Its relationship to microvascularcomplications. Diabetes Care1991; 14: 707-11.
16. Berrut G, Hallab M, Bouhanick B, et al. Value of ambulatoryblood pressure monitoring in type I (insulin-dependent) diabeticpatients with incipient diabetic nephropathy. Am J Hypertens 1994;7: 222-7.
17. Fogari R, Zoppi A, Malamani GD, et al. Urinary albumin excretionand nocturnal blood pressure in hypertensive patients with type IIdiabetes mellitus. Am J Hypertens 1994; 7: 808-13.
18. Sasaki E, Kitaoka H, Ohsawa N. Postprandial hypotension in patientswith non-insulin-dependent diabetes mellitus. Diabetes ResClinPract 1992; 18: 113-21.
19. Cohen CN, Filho FM, de FátimaGonçalves M, de Brito Gomes M. Early alterations of blood pressure in normotensive and normoalbuminuricType 1 diabetic patients. Diabetes Res ClinPract 2001;53: 85-90.
20. Guntsche Z, Saraví FD, Reynals EA, et al. Parental hypertensionand 24 h-blood pressure in children prior to diabetic nephropathy. PediatrNephrol 2002; 17: 157-64.
21. Lengyel Z, Rosivall L, Németh C, et al. Diurnal blood pressurepattern may predict the increase of urinary albumin excretion innormotensive normoalbuminuric type 1 diabetes mellitus patients. Diabetes Res ClinPract 2003; 62: 159-67.
22. Zhao ZY, Zhao ZY, Wang YQ, et al. Quantitative study of circadianvariations of ambulatory blood pressure in Chinese healthy, hypertensive, and diabetes subjects. ClinExpHypertens 2005; 27:187-94.
23. Mannucci E, Lambertucci L, Monami M, et al. Pulse pressure andmortality in hypertensive type 2 diabetic patients. A cohort study. Diabetes Metab Res Rev 2006; 22: 172-5.
24. Cuspidi C, Meani S, Lonati L, et al. Short-term reproducibility of anon-dipping pattern in type 2 diabetic hypertensive patients. J Hypertens2006; 24: 647-53.
25. Darcan S, Goksen D, Mir S, et al. Alterations of blood pressure intype 1 diabetic children and adolescents. PediatrNephrol 2006; 21:672-6.
26. Felício JS, Pacheco JT, Ferreira SR, et al. Hyperglycemia andnocturnal systolic blood pressure are associated with left ventricularhypertrophy and diastolic dysfunction in hypertensive diabeticpatients. CardiovascDiabetol 2006; 5: 19.
27. Leitão CB, Canani LH, Kramer CK, et al. Blood pressure meansrather than nocturnal dipping pattern are related to complications inType 2 diabetic patients. Diabet Med 2008; 25: 308-13.
28. Eguchi K, Pickering TG, Hoshide S, et al. Ambulatory blood pressureis a better marker than clinic blood pressure in predicting cardiovascularevents in patients with/without type 2 diabetes. Am JHypertens 2008; 21: 443-50.
29. Cardoso CR, Leite NC, Freitas L, et al. Pattern of 24-hour ambulatoryblood pressure monitoring in type 2 diabetic patients with cardiovasculardysautonomy. Hypertens Res 2008; 31: 865-72.
30. Kramer CK, Leitão CB, Canani LH, Gross JL. Impact of whitecoathypertension on microvascular complications in type 2 diabetes. Diabetes Care 2008; 31: 2233-7.
31. Eguchi K, Ishikawa J, Hoshide S, et al. Night time blood pressurevariability is a strong predictor for cardiovascular events in patientswith type 2 diabetes. Am J Hypertens 2009; 22: 46-51.
32. Bouhanick B, Bongard V, Amar J, Bousquel S, Chamontin B. Prognostic value of nocturnal blood pressure and reverse-dippingstatus on the occurrence of cardiovascular events in hypertensivediabetic patients. Diabetes Metab 2008; 34: 560-7.
33. Marcovecchio ML, Dalton RN, Schwarze CP, et al. Ambulatoryblood pressure measurements are related to albumin excretion andare predictive for risk of microalbuminuria in young people withtype 1 diabetes. Diabetologia 2009; 52: 1173-81.
34. Rodrigues TC, Canani LH, Viatroski RS, Hoffmann LH, EstevesJF, Gross JL. Masked hypertension, nocturnal blood pressure andretinopathy in normotensive patients with type 1 diabetes. DiabetesRes ClinPract 2010; 87: 240-5.
35. Chatterjee M, Speiser PW, Pellizzarri M, et al. Poor glycemiccontrol is associated with abnormal changes in 24-hour ambulatoryblood pressure in children and adolescents with type 1 diabetesmellitus. J PediatrEndocrinolMetab 2009; 22: 1061-7.
36. Eguchi K, Schwartz JE, Pickering TG, et al. Increased heart ratevariability during sleep is a predictor for future cardiovascularevents in patients with type 2 diabetes. Hypertens Res 2010; 33:737-42.
37. Kramer CK, Leitão CB, Canani LH, Gross JL. Afternoon bloodpressure increase: a blood pressure pattern associated with microvascularcomplications in type 2 diabetes mellitus. Am J Hypertens2011; 24: 64-9.
38. Vílchez-López FJ, Carral-Sanlaureano F, Coserria-Sánchez C, etal. Alterations in arterial pressure in patients with Type 1 diabetesare associated with long-term poor metabolic control and a moreatherogenic lipid profile. J Endocrinol Invest 2011; 34:e24-9.
39. Flores L, Giménez M, Esmatjes E. Prognostic significance of thewhite coat hypertension in patients with type 1 diabetes mellitus. Diabetes Res ClinPract 2006; 74: 21-5.
40. Eguchi K, Hoshide S, Ishikawa J, et al. Cardiovascular prognosisof sustained and white-coat hypertension in patients with type 2diabetes mellitus. Blood Press Monit 2008; 13: 15-20.
41. Bursztyn M, Ben-Dov IZ. White-coat hypertension should not betreated in subjects with diabetes. Diabetes Care 2009; 32: S310-3.
42. Spallone V, Maiello MR, Morganti R, Mandica S, Frajese G. Usefulnessof ambulatory blood pressure monitoring in predicting thepresence of autonomic neuropathy in type I diabetic patients. JHum Hypertens 2007; 21: 381-6.
43. Sharma S, Kavuru M. Sleep and metabolism: an overview. Int JEndocrinol 2010; 2010: 270832.
44. Cugini P, Amato S, Tarquini G, et al. Diagnosing silent cardiacdysautonomia via ambulatory blood pressure monitoring: early diagnosisshown by the lack of heart rate circadian rhythm in type 1diabetes mellitus. ClinTer 2010; 161: e1-10.
45. Ben-Dov IZ, Kark JD, Ben-Ishay D, et al. Blunted heart rate dipduring sleep and all-cause mortality. Arch Intern Med 2007; 167:2116-21.
46. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressuremonitoring. N Engl J Med 2006; 354: 2368-74.
47. Cornélissen G, Chen CH, Halberg F. Ambulatory blood-pressuremonitoring. N Engl J Med 2006; 355: 850.
48. Agarwal R, Kariyanna SS, Light RP. Circadian blood pressureclassification scheme and the health of patients with chronic kidneydisease. Am J Nephrol 2009; 30: 536-46.
49. Gupta AK, Greenway FL, Cornélissen G, Pan W, Halberg F. Prediabetesis associated with abnormal circadian blood pressure variability. J Hum Hypertens 2008; 22: 627-33.
50. Matteucci E, Consani C, Masoni MC, Giampietro O. Circadianblood pressure variability in type 1 diabetes subjects and theirnondiabetic siblings-influence of erythrocyte electron transfer. CardiovascDiabetol 2010; 9: 61.
51. Sanchez De La Pena S, Gonzalez C, Cornélissen G, Halberg F. Blood pressure (BP), heart rate (HR) and non-insulin-dependentdiabetes mellitus (NIDDM) chronobiology. Int J Cardiol 2004; 97:S14.
52. Scheer FA, Hilton MF, Mantzoros CS, Shea SA. Adverse metabolicand cardiovascular consequences of circadian misalignment. ProcNatlAcadSci U S A 2009; 106: 4453-8.
53. Prosser RA, Bergeron HE. Leptin phase-advances the rat suprachiasmaticcircadian clock in vitro. NeurosciLett 2003; 336: 139-42.
54. Hirota T, Okano T, Kokame K, et al. Glucose down-regulates Per1and Per2 mRNA levels and induces circadian gene expression incultured Rat-1 fibroblasts. J BiolChem 2002; 277: 44244-51.
55. Balsalobre A, Marcacci L, Schibler U. Multiple signaling pathwayselicit circadian gene expression in cultured Rat-1 fibroblasts. CurrBiol 2000; 10: 1291-4.
56. Ando H, Takamura T, Matsuzawa-Nagata N, et al. Clock geneexpression in peripheral leucocytes of patients with type 2 diabetes. Diabetologia. 2009; 52: 329-35.
57. Durgan DJ, Pat BM, Laczy B, et al. O-GlcNAcylation, novel posttranslationalmodification linking myocardial metabolism and cardiomyocytecircadian clock. J BiolChem 2011; 286: 44606-19.
58. Su W, Guo Z, Randall DC, et al. Hypertension and disrupted bloodpressure circadian rhythm in type 2 diabetic db/db mice. Am JPhysiol Heart CircPhysiol 2008; 295: H1634-41.
59. Ando H, Kumazaki M, Motosugi Y, et al. Impairment of peripheralcircadian clocks precedes metabolic abnormalities in ob/ob mice. Endocrinology 2011; 152: 1347-54.
60. Kumarasamy S, Gopalakrishnan K, Kim DH, et al. Dysglycemiainduces abnormal circadian blood pressure variability. CardiovascDiabetol2011; 10: 104.
61. Anigbogu CN, Williams DT, Brown DR, et al. Circadian variationsin blood pressure, heart rate, and HR-BP cross-correlation coefficientduring progression of diabetes mellitus in rat. Int J Hypertens2011; 2011: 738689.
62. Randall DC, Speakman RO, Silcox DL, et al. Longitudinal analysisof arterial blood pressure and heart rate response to acute behavioralstress in rats with type 1 diabetes mellitus and in age-matchedcontrols. Front Physiol 2011; 2: 53.
63. Cui H, Kohsaka A, Waki H, et al. Metabolic cycles are linked tothe cardiovascular diurnal rhythm in rats with essential hypertension. PLoS One 2011; 6: e17339.
64. Yoshimoto T, Eguchi K, Sakurai H, et al. Frequency componentsof systolic blood pressure variability reflect vasomotor and cardiacsympathetic functions in conscious rats. J PhysiolSci 2011; 61:373-83.
65. Bostwick J, Nguyen D, Cornélissen G, Halberg F, HoogerwerfWA. Effects of acute and chronic STZ-induced diabetes on clockgene expression and feeding in the gastrointestinal tract. Mol CellBiochem, 2010; 338: 203-13.
66. Isobe Y, Hida H, Nishino H. Circadian rhythm of metabolic oscillationin suprachiasmatic nucleus depends on the mitochondrialoxidation state, reflected by cytochrome C oxidase and lactate dehydrogenase. J Neurosci Res 2011; 89: 929-35.
67. Imai S. "Clocks" in the NAD World: NAD as a metabolic oscillatorfor the regulation of metabolism and aging. BiochimBiophysActa2010; 1804: 1584-90.
68. Delezie J, Challet E. Interactions between metabolism and circadianclocks: reciprocal disturbances. Ann N Y AcadSci 2011;1243: 30-46.
69. Asher G, Schibler U. Crosstalk between components of circadianand metabolic cycles in mammals. Cell Metab 2011; 13: 125-37.
70. Coppari R. Metabolic actions of hypothalamic SIRT1. TrendsEndocrinolMetab 2012; 23: 179-85.
71. Jung-Hynes B, Schmit TL, Reagan-Shaw SR, et al. Melatonin, anovel Sirt1 inhibitor, imparts antiproliferative effects against prostatecancer in vitro in culture and in vivo in TRAMP model. J PinealRes 2011; 50: 140-9.
72. Espino J, Pariente JA, Rodríguez AB. Role of melatonin on diabetes-related metabolic disorders. World J Diabetes 2011; 2: 82-91.
73. Peschke E, Hofmann K, Pönicke K, Wedekind D, Mühlbauer E. Catecholamines are the key for explaining the biological relevanceof insulin-melatonin antagonisms in type 1 and type 2 diabetes. JPineal Res. 2012; 52: 389-96.
74. Cornélissen G, Halberg F, Zeman M, et al. Toward a chronome(time structure) of melatonin. In: Pandi-Perumal SR, Cardinali DP, Eds. Melatonin: From Molecules to Therapy. Nova Science Publishers, Hauppauge NY, 2006; pp. 1-47.
75. Rodríguez-Colón SM, Li X, Shaffer ML, et al. Insulin resistanceand circadian rhythm of cardiac autonomic modulation. CardiovascDiabetol2010; 9:85.
76. Rosengård-Bärlund M, Bernardi L, Fagerudd J, et al.; FinnDianeStudy Group. Early autonomic dysfunction in type 1 diabetes: a reversibledisorder? Diabetologia 2009; 52: 1164-72.
77. Nakano S, Fukuda M, Hotta F, et al. Reversed circadian bloodpressure rhythm is associated with occurrences of both fatal andnonfatal vascular events in NIDDM subjects. Diabetes 1998; 47:1501-6.
78. Lurbe E, Redon J, Kesani A, et al. Increase in nocturnal bloodpressure and progression to microalbuminuria in type 1 diabetes. NEngl J Med 2002; 347: 797-805.
79. Laugesen E, Rossen NB, Poulsen PL, et al. Pulse pressure andsystolic night-day ratio interact in prediction of macrovascular diseasein patients with type 2 diabetes mellitus. J Hum Hypertens2012; 26: 164-70.
80. Otsuka K, Cornélissen G, Halberg F. Predictive value of bloodpressure dipping and swinging with regard to vascular disease risk. Clinical Drug Investigation 1996; 11: 20-31.
81. Cornélissen G, Halberg F, Otsuka K, Singh RB, Chen CH. Chronobiologypredicts actual and proxy outcomes when dipping fails. Hypertension 2007; 49: 237-9.
82. Cornélissen G, Halberg F, Beaty L, et al. Cugini's syndrome instatunascendi: Oratio contra moremprevalentem et pro chronobiologicarationead pressionesanguiniscurandam. La ClinicaTerapeutica2009; 160: e13-e24.
83. Fiser B, Havelkova A, Siegelova J, et al. Night-to-day blood pressureratio during seven-day ambulatory blood pressure monitoring. In: Halberg F, Kenner T, Fiser B, Siegelova J., Eds. NoninvasiveMethods in Cardiology; September 16-17, 2010, Brno, Czech Republic. Brno, Faculty of Medicine, Masaryk University; pp. 128-132.
84. Halberg J, Halberg E, Hayes DK, et al. Schedule shifts, life qualityand quantity--modeled by murine blood pressure elevation and arthropodlife span. Int J Chronobiol1979; 7: 17-64.